Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1980 Aug;55(8):604–607. doi: 10.1136/adc.55.8.604

Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.

A J Martin, C A Smalley, R H George, D E Healing, C M Anderson
PMCID: PMC1627058  PMID: 7436516

Abstract

18 children with cystic fibrosis and mucoid pseudomonas lung infection were treated with courses either of gentamicin plus carbenicillin, or tobramycin plus carbenicillin, with 2 children each receiving two courses. 10 courses of gentamicin at a dose of 9 mg/kg per day plus carbenicillin at 800 mg/kg per day, and 10 courses of tobramycin at 9 mg/kg per day plus carbenicillin at 800 mg/kg per day were given. There was clinical and x-ray improvement in both groups of children, but there was no difference between the therapeutic benefit of either regimen. Pseudomonas aeruginosa was not cultured at the end of treatment after 15 of the 20 courses, but it returned in all but one patient within 3 months. Neither ototoxicity nor renal damage with these high doses of aminoglycoside was detected. P. aeruginosa had not been eliminated when 9 of these patients earlier had received courses of gentamicin in a dose of 6 mg/kg per day plus carbenicillin at 800 mg/kg per day. The results show that P. aeruginosa can successfully be eliminated or suppressed with high-dose aminoglycoside plus carbenicillin, but such elimination is usually short lived.

Full text

PDF
604

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burns M. W., May J. R. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet. 1968 Feb 10;1(7537):270–272. doi: 10.1016/s0140-6736(68)90121-9. [DOI] [PubMed] [Google Scholar]
  2. Chrispin A. R., Norman A. P. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2(2):101–105. doi: 10.1007/BF01314939. [DOI] [PubMed] [Google Scholar]
  3. Govan J. R. Antibiotic therapy and cystic fibrosis: increased resistance of mucoid Pseudomonas aeruginosa to carbenicillin. J Antimicrob Chemother. 1976 Jun;2(2):215–217. doi: 10.1093/jac/2.2.215. [DOI] [PubMed] [Google Scholar]
  4. Hawley H. B., Lewis R. M., Swartz D. R., Gump D. W. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis. Curr Ther Res Clin Exp. 1974 May;16(5):414–423. [PubMed] [Google Scholar]
  5. Hoff G. E., Schiotz P. O., Paulsen J. Tobramycin treatment of pseudomonas aeruginosa infections in cystic fibrosis. Scand J Infect Dis. 1974;6(4):333–337. doi: 10.3109/inf.1974.6.issue-4.07. [DOI] [PubMed] [Google Scholar]
  6. Hoiby N. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):541–550. [PubMed] [Google Scholar]
  7. Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Aug;82(4):551–558. [PubMed] [Google Scholar]
  8. Huang N. N., Hiller E. J., Macri C. M., Capitanio M., Cundy K. R. Carbenicillin in patients with cystic fibrosis: clinical pharmacology and therapeutic evaluation. J Pediatr. 1971 Feb;78(2):338–345. doi: 10.1016/s0022-3476(71)80026-4. [DOI] [PubMed] [Google Scholar]
  9. Marks M. I., Prentice R., Swarson R., Cotton E. K., Eickhoff T. C. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr. 1971 Nov;79(5):822–828. doi: 10.1016/s0022-3476(71)80401-8. [DOI] [PubMed] [Google Scholar]
  10. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. doi: 10.1136/adc.47.256.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mearns M. B. Treatment and prevention of pulmonary complications of cystic fibrosis in infancy and early childhood. Arch Dis Child. 1972 Feb;47(251):5–11. doi: 10.1136/adc.47.251.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Parry M. F., Neu H. C., Merlino M., Gaerlan P. F., Ores C. N., Denning C. R. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin. J Pediatr. 1977 Jan;90(1):144–148. doi: 10.1016/s0022-3476(77)80790-7. [DOI] [PubMed] [Google Scholar]
  13. Williams R. J., Govan J. R. Pyocine typing of mucoid strains of Pseudomonas aeruginosa isolated from children with cystic fibrosis. J Med Microbiol. 1973 Aug;6(3):409–412. doi: 10.1099/00222615-6-3-409. [DOI] [PubMed] [Google Scholar]
  14. Wood R. E., Boat T. F., Doershuk C. F. Cystic fibrosis. Am Rev Respir Dis. 1976 Jun;113(6):833–878. doi: 10.1164/arrd.1976.113.6.833. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES